Incoming 40 million doses of Pfizer COVID-19 vaccine key to herd immunity – Galvez | Inquirer News

Incoming 40 million doses of Pfizer COVID-19 vaccine key to herd immunity – Galvez

/ 05:03 AM June 21, 2021

NO LETUP A health worker on Sunday prepares doses of Pfizer COVID-19 vaccine for hundreds of residents at Emilio Jacinto Elementary School in Tondo, Manila. —MARIANNE BERMUDEZ

MANILA, Philippines — The government has sealed what is so far its biggest COVID-19 vaccine purchase deal, with the signing of an agreement for the delivery of 40 million doses of the vaccine developed by American multinational Pfizer Inc. and German biotechnology company BioNTech SE.

In a statement on Sunday, vaccine czar Carlito Galvez Jr. said he and Health Secretary Francisco Duque III signed a supply agreement with representatives of Pfizer on Saturday.


Galvez called this the “biggest and most decisive deal we ha[ve] for 2021.”

“The vaccines from Pfizer will significantly boost our national immunization program and will enable us to realize our goal of achieving herd immunity by year-end,” said the chief implementer of the National Task Force Against COVID-19.


To achieve herd immunity, the government aims to vaccinate up to 70 percent of the country’s estimated 110 million population.

ADB loan

Galvez said the delivery of the Pfizer doses will begin in October.

Officials of the task force did not disclose the purchase cost when asked, but said Pfizer would be paid directly by the Asian Development Bank (ADB), from which the Philippines borrowed $400 million for the purchase of vaccines.

Galvez said the Philippines has purchased 113 million vaccine doses this year, including the 26 million CoronaVac, 10 million Sputnik V, 20 million Moderna and 17 million AstraZeneca doses.

The COVAX global vaccine pool has also committed to ship in 44 million doses, which brings the total number of expected doses to 157 million—past the number of doses needed to achieve herd immunity.

The country has so far received 9 million CoronaVac, 2.6 million AstraZeneca, 2.5 million Pfizer and 180,000 Sputnik V vaccine doses.

Furthermore, negotiations are ongoing for the supply of an estimated total of 16 million doses from US companies Novavax and Johnson & Johnson.


Virus case update

“Finally, the government has made the right decision. Let’s move quickly,” former government adviser Dr. Tony Leachon said when reached for comment.

More than 8 million Filipinos have so far been inoculated, but only 2.1 million have received their second dose, according to the National Vaccination Operations Center.

Galvez said the target is to increase the daily vaccination rate from the current 322,929 to 500,000 in the next few months.

The Department of Health (DOH) on Sunday reported 5,803 new confirmed COVID-19 cases, down from 6,833 the other day, bringing the total confirmed cases to 1,359,015.

There were 7,652 more recoveries based on the DOH protocol that mild and asymptomatic cases are considered to have recovered after their two-week quarantine.

Total recoveries have reached 1,277,715. Meanwhile deaths rose by 84, including 59 people who were previously tagged as recoveries. This brings the death toll to 23,621.

There are 7,679 active cases, including 115 previously tagged as recoveries.

Among those infected, 91.9 percent are mild cases, 3.7 percent are asymptomatic, 1.29 percent are moderate, 1.8 percent are severe and 1.3 percent are critical.

The DOH said 13.2 percent of 48,073 people who were tested on June 16 were confirmed infected with COVID-19. Two laboratories were not able to submit their data.

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Carlito Galvez Jr., Pfizer COVID-19 vaccine
For feedback, complaints, or inquiries, contact us.

News that matters. Subscribe now

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

© Copyright 1997-2021 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.